Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
12 Drugs Approved for Primary Care in 2019
ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.
New drugs were approved for many conditions commonly treated in primary care in all 4 quarters in 2019 - quite a few of them first-in-class or novel in another way: The first liquid solution of colchicine for gout The first generic Advair Diskus inhaler for asthma and COPD A novel weight-loss drug that is the first approved for BMI as low as 25 25 kg/m2 The first generic naloxone spray The first oral GLP-1 receptor agonist and a glucagon nasal spray for hypoglycemiaIn the spirit of the holiday, we highlight 12 of the 2019 FDA approvals to prep primary care clinicians for 2020.
Related Videos
Related Content
